Autoimmune Disease Diagnostics Market : Popular Trends & Technological Advancements To Watch Out For Near Future; Global Industry Analysis 2023

Global Autoimmune Disease Diagnostics Market Insights

As autoimmune diseases grip millions around the world, the research and development of novel therapeutics and diagnostics is gaining momentum. With the incidence of autoimmune diseases rapidly increasing around the world, efficient autoimmune disease diagnostics is now considered indispensable.

For Any Queries Get Solutions With A PDF Sample : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5351

Compelled by these factors, governments around the world have considerably increased their healthcare spending. The research and development of novel diagnostics has also paced up in the last few years to prevent the spread autoimmune diseases. TMR forecasts that the global autoimmune diseases diagnostics market will expand at a steady CAGR of 3.8% between 2015 and 2023. During the course of the forecast period, price competitiveness among key players will however have an adverse impact on the market’s trajectory.

Nevertheless, with multinational companies capitalizing on opportunities across emerging economies, TMR projects the global autoimmune disease diagnostics market to reach US$17.06 bn by 2023. The market was valued at US$12.3 bn in 2014.

High Awareness about Medical Procedures Puts North America in Dominant Position

Regionally, North America emerged dominant in the global autoimmune disease diagnostics market in 2014, with a share of 39%. In North America, the U.S. and Canada have presently emerged as the most lucrative markets for autoimmune disease diagnostics. Both these countries boast sophisticated healthcare infrastructure with advanced laboratory techniques, and significantly high awareness about various medical procedures. The overall high healthcare expenditure across the region, also puts North America at the fore in the global autoimmune disease diagnostics market.

According to TMR, the North America autoimmune disease diagnostics market at US$4.8 bn in 2014. Rising at a CAGR of 3.7%, the market is expected to reach US$6.6 bn by the end of 2023.

However, Asia Pacific is forecast to emerge as the fastest growing regional market for autoimmune disease diagnostics. The rising demand from countries such as India, Australia, Japan, China, Malaysia, and other emerging nations will bolster opportunities for the market in Asia Pacific. Furthermore, the advances of diagnostic techniques witnessed in Asia Pacific, adoption of sophisticated technologies, and favorable government support will boost the autoimmune disease diagnostics market in the region. As per TMR, the Asia Pacific market will exhibit a CAGR of 4.3% during the course of the forecast period.

High Prevalence of Rheumatoid Arthritis Fuels Demand for Efficient Autoimmune Disease Diagnostics

The most common autoimmune diseases include Graves’ disease, multiple sclerosis, Hashimoto’s thyroiditis, rheumatoid arthritis, type1 diabetes, and systemic lupus erythematosus. Of these, the prevalence of rheumatoid arthritis is the highest since it can occur at any age. Rheumatoid arthritis has therefore emerged as the largest segment in the autoimmune disease diagnostics market, based on disease type. The segment stood at US$3.2 bn in 2014. Rising at a CAGR of 4.2%, it is expected to reach US$4.6 bn by the end of 2022.

The incidence of rheumatoid arthritis is expected to rise in the forthcoming years due to the increasing geriatric population. The segment will also gain from the improved laboratory arrangements for the diagnosis of rheumatoid arthritis. Besides this, the prevalence of type 1 diabetes has been rising globally, which also augments the demand for efficient autoimmune disease diagnostics. TMR expects the type 1 diabetes segment to surge at a CAGR of 3.7% between 2015 and 2023.

View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html

Some of the leading companies operating in the global autoimmune disease diagnostics market are Siemens Healthcare, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., and Abbott Laboratories.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.